NYU Langone Health Expands Comprehensive Lung Cancer Care in Brooklyn

NYU Langone Health’s Perlmutter Cancer Center, a National Cancer Institute–designated Comprehensive Cancer Center, in partnership with NYU Langone Hospital–Brooklyn is growing its state-of-the-art lung cancer care in New York City’s largest borough with a new expansion of treatment and screening services.

Read more

Expert in Early Phase Therapeutics Joins NYU Langone Health as Associate Director for Clinical Research at Perlmutter Cancer Center

Janice M. Mehnert, MD, a nationally recognized expert in early phase therapeutics and the treatment of skin malignancies, has been appointed associate director for clinical research at NYU Langone Health’s Perlmutter Cancer Center. She assumes her post July 1, 2020.

Read more

Lung Cancer Program at NYU Langone Health’s Perlmutter Cancer Center Joins Prestigious Thoracic Surgery Oncology Group

NYU Langone Health has become one of 23 institutions selected to comprise the American Association for Thoracic Surgery’s Thoracic Surgery Oncology Group (TSOG). A North American thoracic surgery clinical trials network, TSOG aims to improve the understanding of thoracic oncologic diseases and enhance the care of patients.

Read more